After new drug’s ‘unprecedented’ results for pancreatic cancer, doctors look at other uses (opens in new tab)

Covers 3 stories including Phase III HUMAN study shows that new pill for patients with advanced pancreatic cancer live significantly longer than standard chemotherapy

The experimental drug daraxonrasib, which doubled survival time in patients with advanced pancreatic cancer, may also prove effective for lung, colon and ovarian cancers.

Read the original article